Perelman School of Medicine: Many Elderly Patients With Metastatic Renal Cell Carcinoma Benefit From Targeted Therapies
June 21, 2019
June 21, 2019
PHILADELPHIA, Pennsylvania, June 21 [TNSmedicalresearch] -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:
* * *
- Penn Study Investigated Real-World Treatment Outcomes Among Medicare Patients
* * *
Many elderly patients with metastatic renal cell carcinoma (RCC)--who are often underrepresented in clinical trials to treat the kidney cancer--are seeing overall survival benefits from treatment with . . .
* * *
- Penn Study Investigated Real-World Treatment Outcomes Among Medicare Patients
* * *
Many elderly patients with metastatic renal cell carcinoma (RCC)--who are often underrepresented in clinical trials to treat the kidney cancer--are seeing overall survival benefits from treatment with . . .